Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fraction Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Protease Inhibitors
1.2.3 Protease
1.2.4 Fibrinolytic Proteins
1.2.5 Coagulation Factors
1.2.6 Anti-Coagulant Proteins
1.3 Market by Application
1.3.1 Global Plasma Fraction Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Fraction Market Perspective (2018-2033)
2.2 Plasma Fraction Growth Trends by Region
2.2.1 Global Plasma Fraction Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Plasma Fraction Historic Market Size by Region (2018-2023)
2.2.3 Plasma Fraction Forecasted Market Size by Region (2024-2033)
2.3 Plasma Fraction Market Dynamics
2.3.1 Plasma Fraction Industry Trends
2.3.2 Plasma Fraction Market Drivers
2.3.3 Plasma Fraction Market Challenges
2.3.4 Plasma Fraction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Fraction Players by Revenue
3.1.1 Global Top Plasma Fraction Players by Revenue (2018-2023)
3.1.2 Global Plasma Fraction Revenue Market Share by Players (2018-2023)
3.2 Global Plasma Fraction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Fraction Revenue
3.4 Global Plasma Fraction Market Concentration Ratio
3.4.1 Global Plasma Fraction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fraction Revenue in 2022
3.5 Plasma Fraction Key Players Head office and Area Served
3.6 Key Players Plasma Fraction Product Solution and Service
3.7 Date of Enter into Plasma Fraction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Fraction Breakdown Data by Type
4.1 Global Plasma Fraction Historic Market Size by Type (2018-2023)
4.2 Global Plasma Fraction Forecasted Market Size by Type (2024-2033)
5 Plasma Fraction Breakdown Data by Application
5.1 Global Plasma Fraction Historic Market Size by Application (2018-2023)
5.2 Global Plasma Fraction Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Plasma Fraction Market Size (2018-2033)
6.2 North America Plasma Fraction Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Plasma Fraction Market Size by Country (2018-2023)
6.4 North America Plasma Fraction Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Fraction Market Size (2018-2033)
7.2 Europe Plasma Fraction Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Plasma Fraction Market Size by Country (2018-2023)
7.4 Europe Plasma Fraction Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Fraction Market Size (2018-2033)
8.2 Asia-Pacific Plasma Fraction Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Plasma Fraction Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasma Fraction Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma Fraction Market Size (2018-2033)
9.2 Latin America Plasma Fraction Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Plasma Fraction Market Size by Country (2018-2023)
9.4 Latin America Plasma Fraction Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Fraction Market Size (2018-2033)
10.2 Middle East & Africa Plasma Fraction Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Plasma Fraction Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasma Fraction Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Plasma Fraction Introduction
11.1.4 Baxter Revenue in Plasma Fraction Business (2018-2023)
11.1.5 Baxter Recent Development
11.2 Octapharma
11.2.1 Octapharma Company Detail
11.2.2 Octapharma Business Overview
11.2.3 Octapharma Plasma Fraction Introduction
11.2.4 Octapharma Revenue in Plasma Fraction Business (2018-2023)
11.2.5 Octapharma Recent Development
11.3 Biotest
11.3.1 Biotest Company Detail
11.3.2 Biotest Business Overview
11.3.3 Biotest Plasma Fraction Introduction
11.3.4 Biotest Revenue in Plasma Fraction Business (2018-2023)
11.3.5 Biotest Recent Development
11.4 CSL
11.4.1 CSL Company Detail
11.4.2 CSL Business Overview
11.4.3 CSL Plasma Fraction Introduction
11.4.4 CSL Revenue in Plasma Fraction Business (2018-2023)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Detail
11.5.2 Grifols Business Overview
11.5.3 Grifols Plasma Fraction Introduction
11.5.4 Grifols Revenue in Plasma Fraction Business (2018-2023)
11.5.5 Grifols Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Detail
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Plasma Fraction Introduction
11.6.4 Kedrion Revenue in Plasma Fraction Business (2018-2023)
11.6.5 Kedrion Recent Development
11.7 LFB
11.7.1 LFB Company Detail
11.7.2 LFB Business Overview
11.7.3 LFB Plasma Fraction Introduction
11.7.4 LFB Revenue in Plasma Fraction Business (2018-2023)
11.7.5 LFB Recent Development
11.8 Chinese Biological Products
11.8.1 Chinese Biological Products Company Detail
11.8.2 Chinese Biological Products Business Overview
11.8.3 Chinese Biological Products Plasma Fraction Introduction
11.8.4 Chinese Biological Products Revenue in Plasma Fraction Business (2018-2023)
11.8.5 Chinese Biological Products Recent Development
11.9 Shanghai RAAS Blood Products
11.9.1 Shanghai RAAS Blood Products Company Detail
11.9.2 Shanghai RAAS Blood Products Business Overview
11.9.3 Shanghai RAAS Blood Products Plasma Fraction Introduction
11.9.4 Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2018-2023)
11.9.5 Shanghai RAAS Blood Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Plasma Fraction Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Protease Inhibitors
Table 3. Key Players of Protease
Table 4. Key Players of Fibrinolytic Proteins
Table 5. Key Players of Coagulation Factors
Table 6. Key Players of Anti-Coagulant Proteins
Table 7. Global Plasma Fraction Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Plasma Fraction Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Plasma Fraction Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Plasma Fraction Market Share by Region (2018-2023)
Table 11. Global Plasma Fraction Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Plasma Fraction Market Share by Region (2024-2033)
Table 13. Plasma Fraction Market Trends
Table 14. Plasma Fraction Market Drivers
Table 15. Plasma Fraction Market Challenges
Table 16. Plasma Fraction Market Restraints
Table 17. Global Plasma Fraction Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Plasma Fraction Market Share by Players (2018-2023)
Table 19. Global Top Plasma Fraction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fraction as of 2022)
Table 20. Ranking of Global Top Plasma Fraction Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Plasma Fraction Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Plasma Fraction Product Solution and Service
Table 24. Date of Enter into Plasma Fraction Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Plasma Fraction Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Plasma Fraction Revenue Market Share by Type (2018-2023)
Table 28. Global Plasma Fraction Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Plasma Fraction Revenue Market Share by Type (2024-2033)
Table 30. Global Plasma Fraction Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Plasma Fraction Revenue Market Share by Application (2018-2023)
Table 32. Global Plasma Fraction Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Plasma Fraction Revenue Market Share by Application (2024-2033)
Table 34. North America Plasma Fraction Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Plasma Fraction Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Plasma Fraction Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Plasma Fraction Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Plasma Fraction Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Plasma Fraction Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Plasma Fraction Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Plasma Fraction Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Plasma Fraction Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Plasma Fraction Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Plasma Fraction Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Plasma Fraction Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Plasma Fraction Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Plasma Fraction Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Plasma Fraction Market Size by Country (2024-2033) & (US$ Million)
Table 49. Baxter Company Detail
Table 50. Baxter Business Overview
Table 51. Baxter Plasma Fraction Product
Table 52. Baxter Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 53. Baxter Recent Development
Table 54. Octapharma Company Detail
Table 55. Octapharma Business Overview
Table 56. Octapharma Plasma Fraction Product
Table 57. Octapharma Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 58. Octapharma Recent Development
Table 59. Biotest Company Detail
Table 60. Biotest Business Overview
Table 61. Biotest Plasma Fraction Product
Table 62. Biotest Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 63. Biotest Recent Development
Table 64. CSL Company Detail
Table 65. CSL Business Overview
Table 66. CSL Plasma Fraction Product
Table 67. CSL Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 68. CSL Recent Development
Table 69. Grifols Company Detail
Table 70. Grifols Business Overview
Table 71. Grifols Plasma Fraction Product
Table 72. Grifols Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 73. Grifols Recent Development
Table 74. Kedrion Company Detail
Table 75. Kedrion Business Overview
Table 76. Kedrion Plasma Fraction Product
Table 77. Kedrion Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 78. Kedrion Recent Development
Table 79. LFB Company Detail
Table 80. LFB Business Overview
Table 81. LFB Plasma Fraction Product
Table 82. LFB Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 83. LFB Recent Development
Table 84. Chinese Biological Products Company Detail
Table 85. Chinese Biological Products Business Overview
Table 86. Chinese Biological Products Plasma Fraction Product
Table 87. Chinese Biological Products Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 88. Chinese Biological Products Recent Development
Table 89. Shanghai RAAS Blood Products Company Detail
Table 90. Shanghai RAAS Blood Products Business Overview
Table 91. Shanghai RAAS Blood Products Plasma Fraction Product
Table 92. Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2018-2023) & (US$ Million)
Table 93. Shanghai RAAS Blood Products Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Fraction Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Plasma Fraction Market Share by Type: 2022 VS 2033
Figure 3. Protease Inhibitors Features
Figure 4. Protease Features
Figure 5. Fibrinolytic Proteins Features
Figure 6. Coagulation Factors Features
Figure 7. Anti-Coagulant Proteins Features
Figure 8. Global Plasma Fraction Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Plasma Fraction Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Plasma Fraction Report Years Considered
Figure 14. Global Plasma Fraction Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Plasma Fraction Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Plasma Fraction Market Share by Region: 2022 VS 2033
Figure 17. Global Plasma Fraction Market Share by Players in 2022
Figure 18. Global Top Plasma Fraction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fraction as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Plasma Fraction Revenue in 2022
Figure 20. North America Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Plasma Fraction Market Share by Country (2018-2033)
Figure 22. United States Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Plasma Fraction Market Share by Country (2018-2033)
Figure 26. Germany Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Plasma Fraction Market Share by Region (2018-2033)
Figure 34. China Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Plasma Fraction Market Share by Country (2018-2033)
Figure 42. Mexico Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Plasma Fraction Market Share by Country (2018-2033)
Figure 46. Turkey Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Plasma Fraction Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Baxter Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 49. Octapharma Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 50. Biotest Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 51. CSL Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 52. Grifols Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 53. Kedrion Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 54. LFB Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 55. Chinese Biological Products Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 56. Shanghai RAAS Blood Products Revenue Growth Rate in Plasma Fraction Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed